|
[1]
|
Poewe, W., Seppi, K., Tanner, C.M., Halliday, G.M., Brundin, P., Volkmann, J., et al. (2017) Parkinson Disease. Nature Reviews Disease Primers, 3, Article No. 17013. https://doi.org/10.1038/nrdp.2017.13
|
|
[2]
|
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S.G., Croteau, D.L., et al. (2019) Ageing as a Risk Factor for Neurodegenerative Disease. Nature Reviews Neurology, 15, 565-581. https://doi.org/10.1038/s41582-019-0244-7
|
|
[3]
|
Athauda, D. and Foltynie, T. (2016) Insulin Resistance and Parkinson’s Disease: A New Target for Disease Modification? Progress in Neurobiology, 145, 98-120. https://doi.org/10.1016/j.pneurobio.2016.10.001
|
|
[4]
|
Xu, T., Dong, W., Liu, J., Yin, P., Wang, Z., Zhang, L., et al. (2024) Disease Burden of Parkinson’s Disease in China and Its Provinces from 1990 to 2021: Findings from the Global Burden of Disease Study 2021. The Lancet Regional Health—Western Pacific, 46, Article 101078. https://doi.org/10.1016/j.lanwpc.2024.101078
|
|
[5]
|
Hogg, E., Athreya, K., Basile, C., Tan, E.E., Kaminski, J. and Tagliati, M. (2018) High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease. Journal of Parkinson’s Disease, 8, 259-265. https://doi.org/10.3233/jpd-181305
|
|
[6]
|
Chang, Y., Park, J., Yun, J.Y. and Song, T.J. (2025) The Association between the Triglyceride-Glucose Index and the Incidence Risk of Parkinson’s Disease: A Nationwide Cohort Study. Journal of Movement Disorders, 18, 138-148. https://doi.org/10.14802/jmd.24131
|
|
[7]
|
Cheng, Y., You, S., Wang, X., Ge, Y., Li, L., Ren, T., et al. (2025) A High Triglyceride-Glucose Index Correlates with Cognitive Impairment in Parkinson’s Disease: A Cross-Sectional Study. Frontiers in Neuroscience, 19, Article 1620118. https://doi.org/10.3389/fnins.2025.1620118
|
|
[8]
|
Cao, H., Zhao, Y., Chen, Z., Zou, X., Du, X., Yi, L., et al. (2025) Triglyceride-Glucose Index Predicts Cognitive Decline and Striatal Dopamine Deficiency in Parkinson Disease in Two Cohorts. npj Parkinson’s Disease, 11, Article No. 240. https://doi.org/10.1038/s41531-025-01100-1
|
|
[9]
|
Qiu, X., Xiao, Y., Wu, J., Gan, L., Huang, Y. and Wang, J. (2019) C-Reactive Protein and Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis. Frontiers in Neurology, 10, Article 384. https://doi.org/10.3389/fneur.2019.00384
|
|
[10]
|
Sawada, H., Oeda, T., Umemura, A., Tomita, S., Kohsaka, M., Park, K., et al. (2015) Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease. PLOS ONE, 10, e0134118. https://doi.org/10.1371/journal.pone.0134118
|
|
[11]
|
Yue, C., Wang, X., Li, Y., Yuan, S., Wang, Z., Liu, H., et al. (2026) Association of the C-Reactive Protein-Triglyceride-Glucose (CTI) Index and Its Central Obesity-Modified Derivatives with Incident Cardiometabolic Multimorbidity: Results from Two Prospective Cohorts in China and England. Cardiovascular Diabetology, 1-45. https://doi.org/10.1186/s12933-026-03238-5
|
|
[12]
|
Liao, C., Liu, L., Bao, W., Lai, H., Tian, R., Zhang, S., et al. (2026) Joint Associations of Anthropometric Indices and C-Reactive Protein-Triglyceride-Glucose Index with Incident Hypertension: A Stratified Analysis by Blood Pressure Level from the CHARLS, 2011-2020. Cardiovascular Diabetology, 25, Article No. 135. https://doi.org/10.1186/s12933-026-03132-0
|
|
[13]
|
Tang, S., Wang, H., Li, K., Chen, Y., Zheng, Q., Meng, J., et al. (2024) C-Reactive Protein-Triglyceride Glucose Index Predicts Stroke Incidence in a Hypertensive Population: A National Cohort Study. Diabetology & Metabolic Syndrome, 16, Article No. 277. https://doi.org/10.1186/s13098-024-01529-z
|
|
[14]
|
Li, H., Chen, L., Wang, M., Cheng, W., Du, Z. and Huang, Y. (2026) Associations of C-Reactive Protein, Triglyceride-Glucose Index, and the C-Reactive Protein-Triglyceride Glucose Index with Multistate Trajectories in the Cardiovascular-Renal-Diabetes Cluster. Frontiers in Endocrinology, 17, Article 1758467. https://doi.org/10.3389/fendo.2026.1758467
|
|
[15]
|
Ke, L., Zhao, L., Xing, W. and Tang, Q. (2024) Association between Parkinson’s Disease and Cardiovascular Disease Mortality: A Prospective Population-Based Study from NHANES. Lipids in Health and Disease, 23, Article No. 212. https://doi.org/10.1186/s12944-024-02200-2
|
|
[16]
|
Zhou, X., Zhao, J., Liu, Y., Sun, X., Li, X., Ren, J., et al. (2024) Association between Serum Potassium and Parkinson’s Disease in the US (NHANES 2005-2020). Frontiers in Neuroscience, 18, Article 1387266. https://doi.org/10.3389/fnins.2024.1387266
|
|
[17]
|
Huang, F., Hao, J., Chen, C., Liu, Q. and He, D. (2025) Reduced Composite Dietary Antioxidant Index Increases the Risk of Parkinson’s Disease and All-Cause Mortality in Parkinson’s Disease Patients: Evidence from the NHANES Database. Frontiers in Aging Neuroscience, 17, Article 1510654. https://doi.org/10.3389/fnagi.2025.1510654
|
|
[18]
|
Ruan, G.T., Xie, H.L., Zhang, H.Y., et al. (2022) A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients with Cancer. Frontiers in Endocrinology, 13, Article 905266. https://doi.org/10.3389/fendo.2022.905266
|
|
[19]
|
Fiory, F., Perruolo, G., Cimmino, I., Cabaro, S., Pignalosa, F.C., Miele, C., et al. (2019) The Relevance of Insulin Action in the Dopaminergic System. Frontiers in Neuroscience, 13, Article 868. https://doi.org/10.3389/fnins.2019.00868
|
|
[20]
|
Lee, J.K., Tran, T. and Tansey, M.G. (2009) Neuroinflammation in Parkinson’s Disease. Journal of Neuroimmune Pharmacology, 4, 419-429. https://doi.org/10.1007/s11481-009-9176-0
|
|
[21]
|
Isik, S., Yeman Kiyak, B., Akbayir, R., Seyhali, R. and Arpaci, T. (2023) Microglia Mediated Neuroinflammation in Parkinson’s Disease. Cells, 12, Article 1012. https://doi.org/10.3390/cells12071012
|
|
[22]
|
Reeve, A., Simcox, E. and Turnbull, D. (2014) Ageing and Parkinson’s Disease: Why Is Advancing Age the Biggest Risk Factor? Ageing Research Reviews, 14, 19-30. https://doi.org/10.1016/j.arr.2014.01.004
|
|
[23]
|
Calabrese, V., Santoro, A., Monti, D., Crupi, R., Di Paola, R., Latteri, S., et al. (2018) Aging and Parkinson’s Disease: Inflammaging, Neuroinflammation and Biological Remodeling as Key Factors in Pathogenesis. Free Radical Biology and Medicine, 115, 80-91. https://doi.org/10.1016/j.freeradbiomed.2017.10.379
|
|
[24]
|
Tenison, E. and Henderson, E.J. (2020) Multimorbidity and Frailty: Tackling Complexity in Parkinson’s Disease. Journal of Parkinson’s Disease, 10, S85-S91. https://doi.org/10.3233/jpd-202105
|
|
[25]
|
Han, M.N., Finkelstein, D.I., McQuade, R.M. and Diwakarla, S. (2022) Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics. Journal of Personalized Medicine, 12, Article 144. https://doi.org/10.3390/jpm12020144
|
|
[26]
|
Ma, K., Xiong, N., Shen, Y., Han, C., Liu, L., Zhang, G., et al. (2018) Weight Loss and Malnutrition in Patients with Parkinson’s Disease: Current Knowledge and Future Prospects. Frontiers in Aging Neuroscience, 10, Article 1. https://doi.org/10.3389/fnagi.2018.00001
|